BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND FANCE, 2178, ENSG00000112039, FAE AND Treatment
4 results:

  • 1.
    Darabi S; Braxton DR; Xiu J; Carneiro BA; Swensen J; Antonarakis ES; Liu SV; McKay RR; Spetzler D; El-Deiry WS; Demeure MJ
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557020
    [No Abstract]    [Full Text] [Related]  

  • 2. Clinicopathological characteristics and genetic variations of uterine tumours resembling ovarian sex cord tumours.
    Ye S; Wu J; Yao L; He J
    J Clin Pathol; 2022 Nov; 75(11):776-781. PubMed ID: 34348985
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment.
    Fumet JD; Limagne E; Thibaudin M; Truntzer C; Bertaut A; Rederstorff E; Ghiringhelli F
    BMC Cancer; 2020 Aug; 20(1):748. PubMed ID: 32778095
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. First clinical experiences with a high field 1.5 T MR linac.
    Bertelsen AS; Schytte T; Møller PK; Mahmood F; Riis HL; Gottlieb KL; Agergaard SN; Dysager L; Hansen O; Gornitzka J; Veldhuizen E; ODwyer DB; Christiansen RL; Nielsen M; Jensen HR; Brink C; Bernchou U
    Acta Oncol; 2019 Oct; 58(10):1352-1357. PubMed ID: 31241387
    [No Abstract]    [Full Text] [Related]  


    of 1.